Adhera Therapeutics, Inc. Deferred Compensation Equity
Adhera Therapeutics, Inc. had Deferred Compensation Equity of $102.60 thousand as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2017-11-13
- 2017-09-30: Deferred Compensation Equity $102.60K.
- 2017-06-30: Deferred Compensation Equity -$216.60K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2017-09-30 | $102.60K 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$216.60K 10-Q · filed 2017-08-14 |